New dystonic syndrome associated with butyrophenone therapy
- 1 January 1972
- journal article
- Published by Springer Nature in Zeitschrift für Neurologie
- Vol. 202 (2), 94-103
- https://doi.org/10.1007/bf00316159
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Distribution in Mice of 14C-γ-(4-methylpiperidino)-p-fluorobutyrophenone hydrochloride (FG5111), a Butyrophenone Derivative with Tranquillizing PropertiesActa Pharmacologica et Toxicologica, 2009
- Striatal Dopamine Release after Amphetamine or Nerve Degeneration Revealed by Rotational BehaviourActa Physiologica Scandinavica, 1971
- Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medicationJournal of the Neurological Sciences, 1968
- EXPERIENCE WITH A NEW BUTYRQPHENONE DERIVATIVE (BURQNIL)Acta Psychiatrica Scandinavica, 1968
- Buronil og promazinbehandling av senildemente: En dobbeltblind undersøkelseNordisk Psykiatrisk Tidsskrift, 1967
- Functional Role of the Nigro‐Neostriatal Dopamine Neurons*)Acta Pharmacologica et Toxicologica, 1966
- Pharmacological and Toxicological Studies on γ‐(4‐methylpiperidino)‐p‐fluorobutyrophenone (FG 5111) ‐ a New Neuroleptic AgentActa Pharmacologica et Toxicologica, 1965
- A syndrome of abnormal movements and dementia in leucotomized patients treated with phenothiazinesJournal of Neurology, Neurosurgery & Psychiatry, 1964
- NEUROLOGICAL SYMPTOMS IN PHARMAGOTHERAPY OF PSYCHOSESActa Psychiatrica Scandinavica, 1964
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963